- Home
- PLRX vs EU Comparison
PLRX vs EU Comparison
Compare PLRX & EU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRX
- EU
- Stock Information
- Founded
- PLRX 2015
- EU 2009
- Country
- PLRX United States
- EU United States
- Employees
- PLRX N/A
- EU N/A
- Industry
- PLRX Biotechnology: Pharmaceutical Preparations
- EU Other Metals and Minerals
- Sector
- PLRX Health Care
- EU Basic Materials
- Exchange
- PLRX Nasdaq
- EU Nasdaq
- Market Cap
- PLRX 641.5M
- EU 724.1M
- IPO Year
- PLRX 2020
- EU N/A
- Fundamental
- Price
- PLRX $12.43
- EU $3.59
- Analyst Decision
- PLRX Strong Buy
- EU Strong Buy
- Analyst Count
- PLRX 7
- EU 2
- Target Price
- PLRX $40.50
- EU $6.50
- AVG Volume (30 Days)
- PLRX 418.7K
- EU 1.1M
- Earning Date
- PLRX 11-07-2024
- EU 11-14-2024
- Dividend Yield
- PLRX N/A
- EU N/A
- EPS Growth
- PLRX N/A
- EU N/A
- EPS
- PLRX N/A
- EU N/A
- Revenue
- PLRX N/A
- EU $44,972,063.00
- Revenue This Year
- PLRX N/A
- EU N/A
- Revenue Next Year
- PLRX $585.71
- EU $109.91
- P/E Ratio
- PLRX N/A
- EU N/A
- Revenue Growth
- PLRX N/A
- EU N/A
- 52 Week Low
- PLRX $10.22
- EU $3.02
- 52 Week High
- PLRX $19.62
- EU $5.05
- Technical
- Relative Strength Index (RSI)
- PLRX 37.61
- EU 40.38
- Support Level
- PLRX $13.55
- EU $3.47
- Resistance Level
- PLRX $15.85
- EU $3.80
- Average True Range (ATR)
- PLRX 0.94
- EU 0.22
- MACD
- PLRX -0.33
- EU -0.03
- Stochastic Oscillator
- PLRX 15.44
- EU 24.14
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About EU enCore Energy Corp.
enCore Energy Corp together with its subsidiary, is engaged in the acquisition and exploration of resource properties. The holds a portfolio of uranium assets located in New Mexico, South Dakota, Wyoming, Texas, Utah, Colorado, and Arizona in the USA, and is advancing its properties with a focus on utilizing in-situ recovery. The company's material properties and projects are the Rosita Project located in Texas, the Alta Mesa Uranium project in Texas, the Crownpoint and Hosta Butte Uranium Project located in New Mexico, the Dewey Burdock Project located in South Dakota, and the Gas Hills Project located in Wyoming.